Jiangdian Wang
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 1
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Mary J. Savage (4 shared papers)Jonathan Juco (2 shared papers)Debra Hanks (2 shared papers)Jared Lunceford (2 shared papers)Kenneth Emancipator (2 shared papers)Karina Kulangara (2 shared papers)Nancy R. Zhang (1 shared paper)Malinka Jansson (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Journal of Computational Biology (1 paper)Archives of Pathology & Laboratory Medicine (1 paper)Clinical Pharmacology Advances and Applications (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesSouth KoreaIsrael
In The Last Decade
Jiangdian Wang
11 papers receiving 868 citations
Jiangdian Wang's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 546
- Gastroenterology 94
- Pulmonary and Respiratory Medicine 264
- Immunology 137
- Surgery 205
Countries citing papers authored by Jiangdian Wang
This map shows the geographic impact of Jiangdian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangdian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangdian Wang more than expected).
Fields of papers citing papers by Jiangdian Wang
This network shows the impact of papers produced by Jiangdian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangdian Wang. The network helps show where Jiangdian Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiangdian Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer Hit paper breakdown → | 2018 | 390 |
| 2 | 2019 | 191 | |
| 3 | 2017 | 127 | |
| 4 | 2018 | 62 | |
| 5 | 2017 | 52 | |
| 6 | 2017 | 19 | |
| 7 | 2018 | 11 | |
| 8 | 2016 | 9 | |
| 9 | 2014 | 7 | |
| 10 | 2020 | 3 | |
| 11 | Shape restricted nonparametric regression based on multivariate Bernstein polynomials | 2012 | 3 |
About Jiangdian Wang
Jiangdian Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 11 papers that have together received 874 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Gastric Cancer Management and Outcomes (3 papers), Advanced Statistical Methods and Models (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Bioinformatics and Genomic Networks (1 paper) and Probabilistic and Robust Engineering Design (1 paper). The work is most often cited by research in Oncology (546 citations), Gastroenterology (94 citations), Pulmonary and Respiratory Medicine (264 citations), Immunology (137 citations) and Surgery (205 citations). Jiangdian Wang has collaborated with scholars based in United States, South Korea and Israel. Frequent co-authors include Mary J. Savage, Jonathan Juco, Debra Hanks, Jared Lunceford, Kenneth Emancipator, Karina Kulangara, Nancy R. Zhang, Malinka Jansson, Supriya Shah and Ellie Corigliano. Their work appears in journals such as Journal of Clinical Oncology, Journal of Computational Biology, Archives of Pathology & Laboratory Medicine, Clinical Pharmacology Advances and Applications and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.